223 related articles for article (PubMed ID: 18697838)
1. Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.
Schmieder AH; Caruthers SD; Zhang H; Williams TA; Robertson JD; Wickline SA; Lanza GM
FASEB J; 2008 Dec; 22(12):4179-89. PubMed ID: 18697838
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis.
Winter PM; Caruthers SD; Zhang H; Williams TA; Wickline SA; Lanza GM
JACC Cardiovasc Imaging; 2008 Sep; 1(5):624-34. PubMed ID: 19356492
[TBL] [Abstract][Full Text] [Related]
3. Minute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbits.
Winter PM; Schmieder AH; Caruthers SD; Keene JL; Zhang H; Wickline SA; Lanza GM
FASEB J; 2008 Aug; 22(8):2758-67. PubMed ID: 18362202
[TBL] [Abstract][Full Text] [Related]
4. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
[TBL] [Abstract][Full Text] [Related]
5. High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 model.
Lijowski M; Caruthers S; Hu G; Zhang H; Scott MJ; Williams T; Erpelding T; Schmieder AH; Kiefer G; Gulyas G; Athey PS; Gaffney PJ; Wickline SA; Lanza GM
Invest Radiol; 2009 Jan; 44(1):15-22. PubMed ID: 18836386
[TBL] [Abstract][Full Text] [Related]
6. Molecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticles.
Schmieder AH; Winter PM; Caruthers SD; Harris TD; Williams TA; Allen JS; Lacy EK; Zhang H; Scott MJ; Hu G; Robertson JD; Wickline SA; Lanza GM
Magn Reson Med; 2005 Mar; 53(3):621-7. PubMed ID: 15723405
[TBL] [Abstract][Full Text] [Related]
7. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.
Winter PM; Neubauer AM; Caruthers SD; Harris TD; Robertson JD; Williams TA; Schmieder AH; Hu G; Allen JS; Lacy EK; Zhang H; Wickline SA; Lanza GM
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2103-9. PubMed ID: 16825592
[TBL] [Abstract][Full Text] [Related]
8. MR angiogenesis imaging with Robo4- vs. alphaVbeta3-targeted nanoparticles in a B16/F10 mouse melanoma model.
Boles KS; Schmieder AH; Koch AW; Carano RA; Wu Y; Caruthers SD; Tong RK; Stawicki S; Hu G; Scott MJ; Zhang H; Reynolds BA; Wickline SA; Lanza GM
FASEB J; 2010 Nov; 24(11):4262-70. PubMed ID: 20585027
[TBL] [Abstract][Full Text] [Related]
9. MR molecular imaging of aortic angiogenesis.
Cai K; Caruthers SD; Huang W; Williams TA; Zhang H; Wickline SA; Lanza GM; Winter PM
JACC Cardiovasc Imaging; 2010 Aug; 3(8):824-32. PubMed ID: 20705262
[TBL] [Abstract][Full Text] [Related]
10. Alphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in mice.
Zhou HF; Chan HW; Wickline SA; Lanza GM; Pham CT
FASEB J; 2009 Sep; 23(9):2978-85. PubMed ID: 19376816
[TBL] [Abstract][Full Text] [Related]
11. Imaging of Vx-2 rabbit tumors with alpha(nu)beta3-integrin-targeted 111In nanoparticles.
Hu G; Lijowski M; Zhang H; Partlow KC; Caruthers SD; Kiefer G; Gulyas G; Athey P; Scott MJ; Wickline SA; Lanza GM
Int J Cancer; 2007 May; 120(9):1951-7. PubMed ID: 17278104
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug.
Pan D; Sanyal N; Schmieder AH; Senpan A; Kim B; Yang X; Hu G; Allen JS; Gross RW; Wickline SA; Lanza GM
Nanomedicine (Lond); 2012 Oct; 7(10):1507-19. PubMed ID: 22709347
[TBL] [Abstract][Full Text] [Related]
13. alphaVbeta3-targeted copper nanoparticles incorporating an Sn 2 lipase-labile fumagillin prodrug for photoacoustic neovascular imaging and treatment.
Zhang R; Pan D; Cai X; Yang X; Senpan A; Allen JS; Lanza GM; Wang LV
Theranostics; 2015; 5(2):124-33. PubMed ID: 25553103
[TBL] [Abstract][Full Text] [Related]
14. αvß3-Integrin-Targeted Magnetic Resonance Imaging for the Assessment of Early Antiangiogenic Therapy Effects in Orthotopic Breast Cancer Xenografts.
Kazmierczak PM; Schneider M; Habereder T; Hirner-Eppeneder H; Eschbach RS; Moser M; Reiser MF; Lauber K; Nikolaou K; Cyran CC
Invest Radiol; 2016 Nov; 51(11):746-755. PubMed ID: 27082316
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles.
Winter PM; Morawski AM; Caruthers SD; Fuhrhop RW; Zhang H; Williams TA; Allen JS; Lacy EK; Robertson JD; Lanza GM; Wickline SA
Circulation; 2003 Nov; 108(18):2270-4. PubMed ID: 14557370
[TBL] [Abstract][Full Text] [Related]
16. Molecular imaging and therapy directed at the neovasculature in pathologies. How imaging can be incorporated into vascular-targeted delivery systems to generate active therapeutic agents.
Guccione S; Li KC; Bednarski MD
IEEE Eng Med Biol Mag; 2004; 23(5):50-6. PubMed ID: 15565799
[TBL] [Abstract][Full Text] [Related]
17. Anti-αvβ3 antibody guided three-step pretargeting approach using magnetoliposomes for molecular magnetic resonance imaging of breast cancer angiogenesis.
Yan C; Wu Y; Feng J; Chen W; Liu X; Hao P; Yang R; Zhang J; Lin B; Xu Y; Liu R
Int J Nanomedicine; 2013; 8():245-55. PubMed ID: 23345972
[TBL] [Abstract][Full Text] [Related]
18. Integrin αvβ3-targeted dynamic contrast-enhanced magnetic resonance imaging using a gadolinium-loaded polyethylene gycol-dendrimer-cyclic RGD conjugate to evaluate tumor angiogenesis and to assess early antiangiogenic treatment response in a mouse xenograft tumor model.
Chen WT; Shih TT; Chen RC; Tu SY; Hsieh WY; Yang PC
Mol Imaging; 2012; 11(4):286-300. PubMed ID: 22954145
[TBL] [Abstract][Full Text] [Related]
19. Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles.
Akers WJ; Zhang Z; Berezin M; Ye Y; Agee A; Guo K; Fuhrhop RW; Wickline SA; Lanza GM; Achilefu S
Nanomedicine (Lond); 2010 Jul; 5(5):715-26. PubMed ID: 20662643
[TBL] [Abstract][Full Text] [Related]
20. Molecular MR imaging of neovascular progression in the Vx2 tumor with αvβ3-targeted paramagnetic nanoparticles.
Schmieder AH; Winter PM; Williams TA; Allen JS; Hu G; Zhang H; Caruthers SD; Wickline SA; Lanza GM
Radiology; 2013 Aug; 268(2):470-80. PubMed ID: 23771914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
